Pituitary gigantism treated successfully with the growth hormone receptor antagonist, pegvisomant
| Data(s) |
2013
|
|---|---|
| Resumo |
A Caucasian male aged 15 years presented with 2 years accelerated linear growth. He was 202 cm tall at presentation, with calculated mid-parental height of 173 cm. There were no features of hypopituitarism or acral growth. His visual fields and optic discs were normal... |
| Identificador | |
| Publicador |
Blackwell Publishing |
| Relação |
DOI:10.1111/imj.12077 Daniel, A., d' Emden, M., & Duncan, E. (2013) Pituitary gigantism treated successfully with the growth hormone receptor antagonist, pegvisomant. Internal Medicine Journal, 43(3), pp. 345-347. |
| Fonte |
Faculty of Health; Institute of Health and Biomedical Innovation |
| Palavras-Chave | #angiopeptin #pegvisomant #somatomedin C #adolescent #androgen therapy #clinical article #gigantism #growth plate #human #hypophysis adenoma #hypophysis disease #letter #male #nuclear magnetic resonance imaging #pituitary gigantism #priority journal #Hormone Antagonists #Human Growth Hormone #Humans #Membrane Proteins #Treatment Outcome |
| Tipo |
Journal Article |
